In Silico Study, Synthesis, and Antineoplastic Evaluation of Thiazole-based Sulfonamide Derivatives and Their Silver Complexes with Expected Carbonic Anhydrase Inhibitory Activity

Overview

Journal J Med Life

Specialty General Medicine

Date 2024 Apr 8

PMID 38585528

Authors

Esraa Mahdi Naji

Noor Hatef Naser

Sahar Aqeel Hussein

Affiliations

Soon will be listed here.

Abstract

This study aimed to design, synthesize, and evaluate the cytotoxic activity of novel thiazole-sulfanilamide derivatives, specifically compounds M3, M4, and M5, through molecular docking and biological assays. The synthesis utilized essential chemical compounds, including sulfanilamide, chloro-acetyl chloride, thiourea, derivatives of benzaldehyde, and silver nitrate. The docking study was carried out using Molecular Operating Environment (MOE) software, and cytotoxic activity was predicted by MTT assay. The synthesized compounds demonstrated a reduction in the viability of cancer cells. Compound M5 had an IC50 of 18.53 µg/ml against MCF-7 cells, comparable to the IC50 of cisplatin. Additionally, compounds M3 and M4 had higher S scores than acetazolamide, indicating greater binding affinity to the active pocket of the receptor. Incorporating the thiazole ring in the synthesized compound augmented their flexibility and affinity for binding to the receptor. The inclusion of the metal complex additionally heightened the compounds' capacity to impede cellular growth.

Citing Articles

In Vitro Evaluate the Antiproliferative Impact of Cnicus Benedictus L. Leaves Methanolic Extract on Cervical Cancer.

Jalil D, Al-Mahdawi T, Jameel M, Talal M Asian Pac J Cancer Prev. 2024; 25(10):3643-3649.

PMID: 39471032 PMC: 11711373. DOI: 10.31557/APJCP.2024.25.10.3643.

References

Kalinin S, Malkova A, Sharonova T, Sharoyko V, Bunev A, Supuran C . Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors. Int J Mol Sci. 2021; 22(24). PMC: 8705727. DOI: 10.3390/ijms222413405. View

Angeli A, Kartsev V, Petrou A, Lichitsky B, Komogortsev A, Pinteala M . Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies. Pharmaceuticals (Basel). 2022; 15(3). PMC: 8955975. DOI: 10.3390/ph15030316. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Guttler A, Theuerkorn K, Riemann A, Wichmann H, Kessler J, Thews O . Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells. Oncol Rep. 2019; 41(4):2585-2594. DOI: 10.3892/or.2019.7001. View

McDonald P, Chafe S, Supuran C, Dedhar S . Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers (Basel). 2022; 14(14). PMC: 9322110. DOI: 10.3390/cancers14143297. View

Supuran C, Scozzafava A, Casini A . Carbonic anhydrase inhibitors. Med Res Rev. 2002; 23(2):146-89. DOI: 10.1002/med.10025. View

Jia T, Ming S, Cao Q, Xu F . Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells. Arch Oral Biol. 2020; 119:104905. DOI: 10.1016/j.archoralbio.2020.104905. View

Arshad M, Alam A, Alshammari A, Alhazza M, Alzimam I, Alam M . Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents. Molecules. 2022; 27(13). PMC: 9268695. DOI: 10.3390/molecules27133994. View

Khushal A, Mumtaz A, Shadoul W, Zaidi S, Rafique H, Munir A . Synthesis, Carbonic Anhydrase II/IX/XII Inhibition, DFT, and Molecular Docking Studies of Hydrazide-Sulfonamide Hybrids of 4-Methylsalicyl- and Acyl-Substituted Hydrazide. Biomed Res Int. 2022; 2022:5293349. PMC: 8894010. DOI: 10.1155/2022/5293349. View

10.

Buza A, Turkes C, Arslan M, Demir Y, Dincer B, Nixha A . Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors. Int J Biol Macromol. 2023; 239:124232. DOI: 10.1016/j.ijbiomac.2023.124232. View

11.

Kilicaslan S, Arslan M, Ruya Z, Bilen C, Ergun A, Gencer N . Synthesis and evaluation of sulfonamide-bearing thiazole as carbonic anhydrase isoforms hCA I and hCA II. J Enzyme Inhib Med Chem. 2016; 31(6):1300-5. DOI: 10.3109/14756366.2015.1128426. View

12.

Martinez-Montiel M, Romero-Hernandez L, Giovannuzzi S, Begines P, Puerta A, Ahuja-Casarin A . Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors. Int J Mol Sci. 2023; 24(11). PMC: 10253577. DOI: 10.3390/ijms24119401. View

13.

capkauskaite E, Zubriene A, Paketuryte V, Timm D, Tumkevicius S, Matulis D . Thiazole-substituted benzenesulfonamides as inhibitors of 12 human carbonic anhydrases. Bioorg Chem. 2018; 77:534-541. DOI: 10.1016/j.bioorg.2018.02.004. View

14.

Bonardi A, Nocentini A, Bua S, Combs J, Lomelino C, Andring J . Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action. J Med Chem. 2020; 63(13):7422-7444. PMC: 8008423. DOI: 10.1021/acs.jmedchem.0c00733. View

15.

Pustenko A, Nocentini A, Gratteri P, Bonardi A, Vozny I, Zalubovskis R . The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 2020; 35(1):1011-1020. PMC: 7178874. DOI: 10.1080/14756366.2020.1752201. View

16.

Manzoor S, Angeli A, Zara S, Carradori S, Rahman M, Raza M . Development of benzene and benzothiazole-sulfonamide analogues as selective inhibitors of the tumor-associated carbonic anhydrase IX. Eur J Med Chem. 2022; 243:114793. DOI: 10.1016/j.ejmech.2022.114793. View

17.

Petrou A, Fesatidou M, Geronikaki A . Thiazole Ring-A Biologically Active Scaffold. Molecules. 2021; 26(11). PMC: 8198555. DOI: 10.3390/molecules26113166. View